Q
uantifying the pupil response to colored light stimuli is a noninvasive technique that objectively assesses rod, cone, and melanopsin activity. [1] [2] [3] [4] In this study, we used chromatic pupillometry to quantify residual rod and cone function in eyes with advanced outer retinal photoreceptor degeneration.
Methods. The study was conducted under the tenets of the Declaration of Helsinki with authorization from the local ethical committee for human research. Four patients with Leber congenital amaurosis (LCA) and 10 control subjects with healthy eyes were studied. The chromatic pupillometer consisted of a ColorDome Ganzfeld bowl (Diagnosys) linked to a dual-channel pupil recorder with a sampling rate of 30 Hz (Arrington Research). 5 Testing was performed under conditions of dark adaptation. Pupil responses to a 1-second red light (640 ± 10 nm) and blue light (467 ± 17 nm), matched for photopic intensity over a 6-log unit range of intensities (−4.0 to 2.0 log cd/m 2 ), were recorded continuously.
The pupil response (pupil size at peak contraction divided by prestimulus baseline size) was plotted against stimulus intensity, and a regression line was fitted through pupil responses to dim light stimuli (−4.0 to −1.0 log cd/m 2 ). The line was extrapolated to intersect through y= 1, where the pupil size at peak contraction was the same as at baseline, indicating the light intensity at which no pupil response can be detected. This intensity was termed the rod-related pupil response threshold (Figure 1) .
In healthy eyes, pupil responses to brighter light intensities derive from mixed rod-cone and melanopsin contributions. In patients whose rod activity is pupillometrically absent, pupil responses to red light (Ն0.5 log cd/ m 2 ) are mediated predominantly by cones and a conerelated response threshold can be similarly estimated from regression analysis.
Inner retinal photoreception mediated by melanopsin was assessed by the difference in sustained pupil contraction between a bright (2.6 log cd/m 2 ) blue and red light stimulus. 4 Results. Control subjects were aged 20 to 52 years, and patients with LCA were aged 15 to 44 years. Genetic analysis of patients revealed an RDH mutation in 2 patients, an RPE65 mutation in 1, and a TULP mutation in 1. Neither rod nor cone activity was detectable by electroretinography in any patient. Visual acuities ranged from 20/200 to light perception. Kinetic visual fields were unobtainable in 1 patient and severely constricted in the others.
In healthy eyes, rod-mediated pupil responses to dim light stimuli were easily recordable and showed a greater sensitivity to blue light compared with red light, consistent with the spectral sensitivity of rods. Patients with LCA had severely reduced or absent pupil responses to light intensities below −1.0 log cd/m 2 (Figure 2) . The rod-related pupil response threshold was quantifiable in only 1 patient (−3.1 log cd/m 2 ), being almost 2 log units greater than the control mean (−4.9 log cd/m 2 ). In contrast, pupil responses to brighter stimulus intensities were readily present in all patients and a cone-related response threshold was quantifiable (range, −2.3 to −0.8 log cd/m 2 ). Melanopsin activity was not significantly different between patients with LCA and control subjects.
Comment. Pupil responses to dim stimulus lights under conditions of dark adaptation derive from isolated rod activation and permit determination of the rodrelated pupil response threshold. In advanced stages of LCA, degenerating rods have lost their contribution to afferent retinal signaling so that residual cones and melanopsin are the mediators of the pupil light reflex. In such patients, cone function can be separated from melanopsin and quantified from pupil responses to bright red stimulus lights. Determination of the pupil response threshold from rods and cones has a greater dynamic range than standard electroretinography for quantifying low levels of outer retinal photoreceptor activity in patients with retinal degeneration. Early Refractive Outcome After Intravitreous Bevacizumab for Retinopathy of Prematurity R etinopathy of prematurity (ROP) is a neovascular retinal disease that has usually been treated by peripheral argon laser coagulation. Retinal laser coagulation has disadvantages and adverse effects such as the need for general anesthesia, scarring of the peripheral retina and choroid, and presumably induction of myopization.
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Based on the role of vascular endothelial growth factor in retinal neovascularization, recent studies have shown the therapeutic effect of intravitreous bevacizumab as a vascular endothelial growth factor inhibitor for the therapy of ROP.
3, 4 Besides the short-term effects of this anti-vascular endothelial growth factor therapy in terms of a regression of retinal neovascularization, effects of the therapy on the development of myopia have not yet been examined. We therefore assessed the refractive error of children who had received intravitreous bevacizumab for therapy of ROP.
Methods.
The prospective study included all children who had been treated with an intravitreous injection of bevacizumab (0.375 mg; Avastin) for ROP threshold disease in posterior zone 2 or zone 1 or for prethreshold ROP in zone 1. Diagnosis was based on the guidelines of the International Committee for the Classification of Retinopathy of Prematurity. 5 The study group was compared with a control group that had previously undergone retinal argon laser therapy of ROP in the same center and was matched with the study group for birth weight, gestational age, and length of followup. The follow-up examination included sciascopy and automated refractometry (Retinomax 3; Nikon) under cycloplegic conditions and examination of the anterior and posterior segments of the eye.
Results. The study group consisted of 12 eyes of 6 children with a mean (SD) birth weight of 627 (116) g and a mean (SD) age of 24.8 (1.2) weeks. The follow-up examination was performed at a mean (SD) corrected age of 10.5 (2.7) months (Table) . The control group included 20 eyes of 10 children (Table) . The mean refractive errors for the right eyes and left eyes were significantly less myopic in the study group than in the control group (P =.03 for the right eyes; P=.02 for the left eyes) (Table) . Refractive astigmatism did not differ significantly between the groups. An additional child received an intravitreous injection of bevacizumab in her left eye in which an excessive tunica vasculosa lentis prevented retinal laser therapy, and she received retinal argon laser coagulation in her right eye. At a corrected age of 29 months, the refractive error was −8.00 diopters (D) OS and −10.25 D OD. The right eye after laser therapy showed macular ectopia, while the posterior pole of the left eye was unremarkable. 
